Sophie Duvert-Lehembre Selected Research

Desmogleins

1/2020

Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sophie Duvert-Lehembre Research Topics

Disease

5	Pemphigus (Pemphigus Vulgaris) 01/2024 - 05/2013
3	Bullous Pemphigoid (Pemphigoid) 10/2023 - 05/2013
2	Pemphigoid Gestationis (Herpes Gestationis) 06/2023 - 03/2017
1	Wounds and Injuries (Trauma) 11/2023
1	Blister (Bulla) 06/2023
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2021
1	Skin Diseases (Skin Disease) 01/2019
1	Muscular Diseases (Myopathy) 05/2017
1	Pathologic Complete Response 05/2017
1	Neoplasms (Cancer) 05/2013

Drug/Important Bio-Agent (IBA)

4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 10/2013
4	EnzymesIBA 01/2022 - 05/2013
4	ImmunosorbentsIBA 01/2022 - 05/2013
3	Rituximab (Mabthera)FDA Link 01/2024 - 05/2017
2	AntibodiesIBA 06/2023 - 01/2022
1	Omalizumab (Xolair)FDA Link 10/2023
1	Immunoglobulin G (IgG)IBA 06/2023
1	VemurafenibIBA 01/2021
1	DesmogleinsIBA 01/2020
1	Immunoglobulin A (IgA)IBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 05/2017
1	SaltsIBA 05/2013
1	AutoantibodiesIBA 05/2013
1	KalininIBA 05/2013
1	Matrix Metalloproteinases (MMPs)IBA 05/2013

Therapy/Procedure

5	Therapeutics 01/2024 - 10/2013
2	Aftercare (After-Treatment) 01/2022 - 01/2020
1	Nursing Care 11/2023
1	Contraindications 10/2023
1	Duration of Therapy 10/2013